Op deze pagina vindt u het laatste nieuws uit de wereld van klinisch onderzoek! Voor het nieuwsoverzicht (nieuwsfeed) op deze pagina worden van een aantal organisaties, instanties, bedrijven en personen de RSS feeds gevolgd. De RSS feeds worden elke 5 – 10 minuten ververst en op deze pagina weergegeven. Voor een overzicht van alle nieuwsbronnen, klik hier.
Omdat de plug-in die ik voor deze pagina gebruik niet overweg kan met de RSS feeds van een aantal organisaties, instanties, bedrijven en personen heb ik een alternatieve pagina ingericht om de RSS feeds van deze organisaties, instanties, bedrijven en personen toch weer te kunnen geven. Klik hier om het alternatieve nieuwsoverzicht te raadplegen.
Meer nieuws en actualiteiten:
- Alternatief nieuwsoverzicht
- Archief Nieuwsbrief voor Goede Onderzoekspraktijken
- Uitgelicht & Gespot op internet
Nieuwsfeed
- The RW Daily: "Put pressure on publishers to follow best practice — external regulation is the answer." And Turkey's decision to stick with Scopus.
- The Bizarre and Dangerous Concept of Over-Vaccination
- Drug Trials Snapshots: VIZZ
- Drug Trials Snapshots: LYNKUET
- Advanced Manufacturing Technologies Designation Program
- Trial Matching, Source Data, And More: How Clinical Researchers Used AI In 2025
- Untitled Letters
- Subsidie langs de meetlat: Subsidieregeling Regeneratief Geneeskundige Onderzoeksprojecten
- Unipack LLC - 716621 - 12/19/2025
- Devalingam Mahalingam, M.D., Ph.D. - 721145 - 12/11/2025
- Private Label Skin Care, Inc. - 715880 - 12/18/2025
- Agebox Inc. - 718252 - 12/19/2025
- Walgreen Company - 662158 - 12/19/2025
- Walgreen Company - 662158 - 09/12/2023
- The RW Daily: Cheers to 2025: Retraction Watch's year in review. And "Prominent environmental health journal disappears, but it’s in transition"
- Cheers to 2025: In which Retraction Watch turned 15, and The Center For Scientific Integrity really became a center
- Richtlijn uitvoering euthanasie aangepast: meer duidelijkheid over zeldzame situaties
- Factors associated with enrollment in a randomized clinical trial of docosahexaenoic supplementation in toddlers born preterm
- Patent Certifications and Suitability Petitions
- Drug Trials Snapshot: RHAPSIDO
- 2025 Biological License Application Approvals
- Biological Product Deviation Reports Annual Summaries
- Generic Drugs Program Monthly and Quarterly Activities Report
- FDA Further Expands And Clarifies Expanded Access FAQs
- CDER/Office of New Drugs Streamlined Nonclinical Studies and Acceptable New Approach Methodologies (NAMs)
- Over-The-Counter Monograph Drug User Fee Program (OMUFA)
- Other | Cancer Accelerated Approvals
- The RW Daily: The BMJ retracts clinical trial for ‘severe’ discrepancies in randomization
- The BMJ retracts clinical trial for ‘severe’ discrepancies in randomization
- Top Stories of 2025: AI in Clinical Research, Pharmacy Recruitment, Pragmatic Trials
- The top stories of 2025 from EARA
- Atlas reveals brain cell diversity in mice and marmoset brains
- Anti-inflammatory drugs prolong breast cancer therapy in mice
- Weekend reads: Court tosses out challenge to ORI funding ban; prof steps down after AI citation scandal; senator seeks journal’s COVID-19 manuscripts
- Weekend reads: Court tosses out challenge to ORI funding ban; prof steps down after AI citation ‘scandal’; senator seeks journal’s COVID-19 manuscripts
- Gold Star Distribution Inc., Issues Recall of Certain FDA-Regulated Products in Three States Including Drugs, Devices, Cosmetics, Human Foods, and Pet Foods
- The Rise Of Antimicrobial Resistance And Strategic Research Imperatives For 2026
- The RW Daily: The Retraction Watch Hijacked Journal Checker now has 400 entries
- The Retraction Watch Hijacked Journal Checker now has 400 entries
- Desirability of outcome ranking (DOOR) analysis for multivariate survival outcomes with application to ACTT-1 trial
- The RW Daily: Court tosses out researcher’s bid to overturn funding ban. And a paper by neuroscientist retracted 3 years after getting an EOC.
- List of Determinations Including Written Request
- What's New Related to Drugs
- Novel Drug Approvals for 2025
- Drug Trials Snapshots
- Drug Trials Snapshots: DAWNZERA
- Drug Trials Snapshots: HERNEXEOS
- CDER Data Standards Program
- Data Standards Program Strategic Plan and Board
- Generic Drug Facilities, Sites and Organization Lists
